Cetera Investment Advisers Horizon Therapeutics Public LTD CO Transaction History

Cetera Investment Advisers

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $223,855 - $408,314	3,588 New	3,588 $408,000
Q2 2022 Aug 11, 2022	SELL	$79.4 - $116.36 $23,502 - $34,442	-296 Reduced 10.3%	2,578 $206,000
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $23,074 - $29,319	267 Added 10.24%	2,874 $302,000
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $38,635 - $47,004	392 Added 17.7%	2,607 $281,000
Q3 2021 Nov 16, 2021	SELL	$91.91 - $110.37 $11,764 - $14,127	-128 Reduced 5.46%	2,215 $243,000
Q2 2021 Aug 13, 2021	BUY	$86.24 - $95.92 $202,060 - $224,740	2,343 New	2,343 $219,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

Stay updated on Cetera Investment Advisers with notifications on news.